These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1907709)

  • 1. Cost-effectiveness concepts and the CE plane.
    Ganiats TG
    Med Decis Making; 1991; 11(2):147. PubMed ID: 1907709
    [No Abstract]   [Full Text] [Related]  

  • 2. The CE plane: a graphic representation of cost-effectiveness.
    Black WC
    Med Decis Making; 1990; 10(3):212-4. PubMed ID: 2115096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Roaming through methodology. XIX. Cost-effectiveness ratios].
    Rutten FF
    Ned Tijdschr Geneeskd; 2000 Jul; 144(27):1311-4. PubMed ID: 10918910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical analysis of cost effectiveness data.
    O'Brien B
    J Rheumatol; 1999 Oct; 26(10):2078-80. PubMed ID: 10529119
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistical issues in cost-effectiveness analyses.
    Thompson S
    Stat Methods Med Res; 2002 Dec; 11(6):453-4. PubMed ID: 12516983
    [No Abstract]   [Full Text] [Related]  

  • 6. Using propensity scores to estimate the cost-effectiveness of medical therapies.
    Indurkhya A; Mitra N; Schrag D
    Stat Med; 2006 May; 25(9):1561-76. PubMed ID: 16158412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian modeling of cost-effectiveness studies with unmeasured confounding: a simulation study.
    Stamey JD; Beavers DP; Faries D; Price KL; Seaman JW
    Pharm Stat; 2014; 13(1):94-100. PubMed ID: 24446072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty.
    Briggs A
    Value Health; 2005; 8(1):1-2. PubMed ID: 15841888
    [No Abstract]   [Full Text] [Related]  

  • 9. Bayesian estimation of cost-effectiveness from censored data.
    Heitjan DF; Kim CY; Li H
    Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonparametric statistical methods for cost-effectiveness analyses.
    Dinh P; Zhou XH
    Biometrics; 2006 Jun; 62(2):576-88. PubMed ID: 16918923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit-cost analysis in public health.
    Lave LB; Joshi SV
    Annu Rev Public Health; 1996; 17():203-19. PubMed ID: 8724224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should commercial-in-confidence data be used by decision makers when making assessments of cost-effectiveness?
    Drummond M
    Appl Health Econ Health Policy; 2002; 1(2):53-4. PubMed ID: 14619251
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost effectiveness of early detection.
    Siu TO
    Health Serv Res; 1976; 11(3):302. PubMed ID: 828154
    [No Abstract]   [Full Text] [Related]  

  • 14. Power and sample size in cost-effectiveness analysis.
    Laska EM; Meisner M; Siegel C
    Med Decis Making; 1999; 19(3):339-43. PubMed ID: 10424840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of sunitinib.
    Trippoli S; Messori A
    J Clin Oncol; 2008 Dec; 26(35):5829; author reply 5829-30. PubMed ID: 19001342
    [No Abstract]   [Full Text] [Related]  

  • 16. Using inverse-weighting in cost-effectiveness analysis with censored data.
    Willan AR; Lin DY; Cook RJ; Chen EB
    Stat Methods Med Res; 2002 Dec; 11(6):539-51. PubMed ID: 12516988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis and innovation.
    Jena AB; Philipson TJ
    J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A framework for cost-effectiveness analysis from clinical trial data.
    O'Hagan A; Stevens JW
    Health Econ; 2001 Jun; 10(4):303-15. PubMed ID: 11400253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating incremental cost-effectiveness ratios and their confidence intervals with differentially censored data.
    Wang H; Zhao H
    Biometrics; 2006 Jun; 62(2):570-5. PubMed ID: 16918922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.
    Briggs AH; O'Brien BJ; Blackhouse G
    Annu Rev Public Health; 2002; 23():377-401. PubMed ID: 11910068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.